Alcon

Alcon ALC Stock

$70.17   -0.651280%
Add to favorites
Exchange
Market Cap
$33.92B
LOW - HIGH [24H]
$69.54 - $70.46
VOLUME [24H]
$2.59M
P/E Ratio
53.15
Earnings per share
$1.32
ISIN
CH0432492467
Price   Prediction

Alcon Price Chart

Sorry, that's all we've gotfor now...

Alcon ALC Financial and Trading Overview

Alcon stock price 70.17 USD
Previous Close 70.63 USD
Open 70.16 USD
Bid 67.2 USD x 30000
Ask 73.5 USD x 10000
Day's Range 69.54 - 70.46 USD
52 Week Range 61.84 - 87.64 USD
Volume 2.59M USD
Avg. Volume 1.79M USD
Market Cap 33.92B USD
Beta (5Y Monthly) 0.726
PE Ratio (TTM) 53.15909
EPS (TTM) 1.32 USD
Forward Dividend & Yield 0.36 (0.50%)
Ex-Dividend Date May 6, 2026
1y Target Est 82.73 USD

ALC Valuation Measures

Enterprise Value 37.76B USD
Trailing P/E 53.15909
Forward P/E 17.698824
PEG Ratio (5 yr expected) 1.26
Price/Sales (ttm) 3.1231172
Price/Book (mrq) 1.5707474
Enterprise Value/Revenue 3.477
Enterprise Value/EBITDA 15.708

Trading Information

Alcon Stock Price History

Beta (5Y Monthly) 0.726
52-Week Change -7.79%
S&P500 52-Week Change 10.88%
52 Week High 87.64 USD
52 Week Low 61.84 USD
50-Day Moving Average 67.96 USD
200-Day Moving Average 72.19 USD

ALC Share Statistics

Avg. Volume (3 month) 1.79M USD
Avg. Daily Volume (10-Days) 1.79M USD
Shares Outstanding 483.4M
Float 481.83M
Short Ratio 10.44
% Held by Insiders 0.19%
% Held by Institutions 63.09%
Shares Short 17.88M
Short % of Float N/A
Short % of Shares Outstanding 3.69%

Dividends & Splits

Trailing Annual Dividend Rate 0.353
Trailing Annual Dividend Yield 0.49%
5 Year Average Dividend Yield 28.99%
Payout Ratio 0.2656
Last Split Factor

Financial Highlights

Fiscal Year

Fiscal Year Ends December 31, 2025
Most Recent Quarter (mrq) June 30, 2026
Next Fiscal Year End December 31, 2026

Profitability

Profit Margin 5.91%
Operating Margin (ttm) 14.63%
Gross Margin 57.22%
EBITDA Margin 22.13%

Management Effectiveness

Return on Assets (ttm) 2.79%
Return on Equity (ttm) 2.94%

Income Statement

Revenue (ttm) 10.86B USD
Revenue Per Share (ttm) 22.21 USD
Quarterly Revenue Growth (yoy) 8.69%
Gross Profit (ttm) 6.22B USD
EBITDA 2.4B USD
Net Income Avi to Common (ttm) 643M USD
Diluted EPS (ttm) 1.32
Quarterly Earnings Growth (yoy) -100.00000000000000000000000000000000%

Balance Sheet

Total Cash (mrq) 1.46B USD
Total Cash Per Share (mrq) 3.01 USD
Total Debt (mrq) 5.3B USD
Total Debt/Equity (mrq) 24.54 USD
Current Ratio (mrq) 2.092
Book Value Per Share (mrq) 44.673

Cash Flow Statement

Operating Cash Flow (ttm) 2.31B USD
Levered Free Cash Flow (ttm) 1.27B USD

Profile of Alcon

Country United States
State N/A
City Geneva
Address Chemin de Blandonnet 8
ZIP 1214
Phone 41 589 112 110
Website https://www.alcon.com
Industry Medical Instruments & Supplies
Sector(s) Healthcare
Full Time Employees 25000

Alcon Inc. researches, develops, manufactures, distributes, and sells eye care products worldwide. The company operates through two segments, Surgical and Vision Care. It offers equipment, instrumentation and diagnostics, intraocular lenses (IOLs), and other implantables; and consumables, including viscoelastics, surgical solutions, incisional instruments, surgical custom packs, and other products for surgical procedures. The company's cataract products include Unity CS, LenSx laser system, Verion reference unit and Verion digital marker, ARGOS biometer, SMARTCATARACT health platform, NGENUITY 3D visualization system, LuxOR surgical ophthalmic microscope, and ORA system for intra-operative measurements; ADI cloud-based platform; and implantable products, including monofocal, Toric, and Presbyopia-Correcting IOLs, as well as delivery systems, such as AutonoMe and UltraSert. In addition, it provides Custom Pak surgical procedure packs vitreoretinal products comprising constellation vision systems, procedure packs, lasers and hand-held microsurgical instruments, Grieshaber, MIVS instruments; scissors, forceps and micro-instruments, medical grade vitreous tamponades, and Hypervit probes; and refractive surgery products, including WaveLight and Contoura Vision used for LASIK refractive procedure. Further, the company offers daily disposable, reusable, and color-enhancing contact lenses; ocular health products, such as dry eye, ocular allergies, glaucoma, and contact lens care, as well as ocular vitamins and redness relievers. In addition it also develops and commercializes therapies for chronic eye diseases, focusing on encapsulated cell therapy platforms for ocular conditions. The company was formerly known as Alcon Universal S.A. and changed its name to Alcon Inc. in December 2001. Alcon Inc. was founded in 1945 and is headquartered in Geneva, Switzerland.

Q&A For Alcon Stock

What is a current ALC stock price?

Alcon ALC stock price today per share is 70.17 USD.

How to purchase Alcon stock?

You can buy ALC shares on the NYSE exchange. Contact your financial advisor to select a broker.

What is the ticker symbol for Alcon?

The stock symbol or ticker of Alcon is ALC.

Which industry does the Alcon company belong to?

The Alcon industry is Medical Instruments & Supplies.

How many shares does Alcon have in circulation?

The max supply of Alcon shares is 483.4M.

What is Alcon Price to Earnings Ratio (PE Ratio)?

Alcon PE Ratio is 53.15909000 now.

What was Alcon earnings per share over the trailing 12 months (TTM)?

Alcon EPS is 1.32 USD over the trailing 12 months.

Which sector does the Alcon company belong to?

The Alcon sector is Healthcare.

Alcon ALC included in indexes

Name Name Price Price 24h%
7d chart
24h% & 7d
VOL Volume 24h low 24h high Volume
Name Name Price Price 24h%
7d chart
24h% & 7d
VOL Volume 24h low 24h high Volume
{{ item.symbol }} {{ item.name }} {{ item.symbol }} {{ item.country.toUpperCase() }} {{ item.price }} {{ item.price_usd }}
{{ item.change_pct }}
{{ item.volume }} {{ item.volume_usd }} {{ item.low }} {{ item.low_usd }} {{ item.high }} {{ item.high_usd }} {{ item.components_count }} {{ item.volume }} {{ item.volume_usd }}
us NYSE Composite Index NYA US 24117.27 USD —
-0.65
— — — — — — — — —
$2.67T
Total marketcap
$42.56B
Total volume
BTC 60.00%   •   ETH 10.58%
Dominance
Select currency